Indi Xpresys Lung Helps Identify Benign Lung Nodules, Lower Patient Anxiety, Decrease Unnecessary Surgery, and Decrease Costs
Lung Cancer, News
Seattle-based Indi (Integrated Diagnostics) has announced publication in the Journal of Thoracic Oncology (JTO) reporting positive results from a landmark clinical trial that confirms the firm’s Xpresys Lung laboratory-based molecular ... Read more